ArticleOncology letters2026
Identifying an appropriate endogenous control for real-time PCR of microRNAs in colorectal liver metastases: A comparison of 18s rRNA and small nuclear RNA RNU6B.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selection of an appropriate housekeeping gene as an endogenous control is essential for obtaining reliable results in semi-quantitative real-time (RT-)PCR. However, the cellular composition varies according to the site of metastasis, resulting in differences among tissue compartments. Consequently, a suitable endogenous control for microRNA (miRNA) PCR may differ depending on the target organ, making individual evaluation of candidate controls necessary. In the present study, liver metastases were investigated, and RNU6B was compared with the well-established 18s ribosomal RNA (18s rRNA), commonly used in mRNA PCR, to determine which gene is more suitable as an endogenous control for miRNA analysis in colorectal liver metastases (CLM). A total of 79 patients with stage IV colorectal carcinoma who underwent liver resection were included. RNA, including miRNA, was extracted and analyzed using RT-PCR. The expression levels of RNU6B and 18s rRNA in CLM tissues and paired healthy liver tissues were assessed, and compared with the characteristics of a theoretically ideal endogenous control. The mean Cq values of RNU6B were significantly lower than those of 18s rRNA in both CLM tissues and corresponding healthy liver tissues (P<0.001). Pearson correlation analysis demonstrated a strong correlation between CLM and healthy liver tissues for RNU6B (correlation coefficient ϱ=0.807), whereas only a weak correlation was observed for 18s rRNA (ϱ=0.398). Furthermore, the slope and y-intercept of the regression line for RNU6B were closer to those of an ideal regression line than those for 18s rRNA. Clinical parameters, including sex, age, primary tumor localization and stage, and chronicity of liver metastases, did not significantly influence the expression of either RNU6B or 18s rRNA. Overall, RNU6B demonstrated greater conformity to the characteristics of an ideal endogenous control than 18s rRNA for miRNA PCR in CLM tissues. Based on these findings, RNU6B is recommended as an endogenous control for RT-PCR analysis of miRNAs in metastatic colorectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.